A 2026 systematic review and meta-analysis of randomized controlled trials confirmed that GLP-1 receptor agonists produce clinically meaningful weight loss across diverse patient populations (Ahmad et al., 2026, PMID: 41824845)
Well outline our pharmacist-led approach to clinical oversight, ensuring your weight management journey is seamless, tranquil, and anchored in the highest standards of UK clinical governance
A common question
Now that we have negotiated lower prices for CVS Caremark clients, more of those employers will be able to provide coverage to their populations for GLP-1s for weight loss
How to Start Talking About It With Your Provider Ask questions such as, How might this medication affect my sexual desire, body image, or intimacy? Even if there are no clear answers yet, the conversation matters
There are no required monthly check-ins